This site is optimised for modern browsers. For the best experience, please use Google Chrome, Mozilla Firefox, or Microsoft Edge.

    Screening, prevention and Early detection (SPED) Sub Specialty Research Lead

    Closing date: 31 December 2022

    Oversight of the delivery of the national cancer research portfolio is managed through the Research Delivery Directorate and is broken down into thirteen areas overseen by an SSRL in support of the Research Speciality leads; Lung, Breast, Colorectal, Upper GI, Urology, Gynae, Head and neck, brain, palliative care, Children and young people, radiotherapy, sarcoma and skin. The SPED role is a new strategic post which is likely to span several specialities / and subspecialty areas although it is likely to primarily sit with the cancer portfolio.